Stage II (N1) lung cancer

Chest Surgery Clinics of North America

Volumn 11, Issue 1, 2001, Pages 39-59

  Choy, O ^a   Jahan, T ^a   You, L ^a   Roach III, M ^a   Jablons, D ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; MITOMYCIN; NAVELBINE; PACLITAXEL; UFT; VINDESINE;

BRONCHOPLEURAL FISTULA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING;

EID: 0035099553     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Combined therapy: Irradiation and surgery in the treatment of bronchogenic carcinoma
2. Mediastinal lymph node dissection in resected lung cancer: Morbidity and accuracy of staging
3. Induction chemotherapy with mitomycin, vindesine and cis-platinum for stage III unresectable -small cell lung cancer: Results of the Toronto phase II trial
4. The new lung cancer staging system. What does it mean?
5. Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors
6. Phase III trial of neo adjuvant chemotherapy in resectable stage I, II, IIIA non-small cell lung cancer: The French experience
7. Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer
8. Adjuvant chemotherapy with cyclophosphamide, doxorubicin and cisplatinum in patients with completely resected stage I non-small cell lung cancer
9. What is new in nuclear medicine imaging?
10. Anti-angiogenesis: New concepts for therapy of solid tumors
11. What is the evidence that tumors are angiogenesis dependent?
12. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
13. Video-assisted minithoracotomy versus muscle-sparing thoracotomy for performing lobectomy
14. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
15. Early Lung Cancer Action Project: Overall design and findings from baseline screening
16. Surgical adjuvant chemotherapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma
17. Controlled Study with Adjuvant Radiotherapy, Chemotherapy, Immunotherapy and Chemoimmunotherapy in Operable Squamous Carcinoma of the Lung
18. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer
19. A feasibility study of neoadjuvant vinorelbine and cis-platinum for patients with early stage, resectable non-small cell lung cancer
20. Clinical Strategies of Cancer Treatment: The Role of Drugs
21. Complete mediastinal lymph node dissection improves survival in patients with resected stages II and IIIa non-small cell lung cancer
22. PET, CT, and MRI with Combidex for medianstinal staging in non-small cell lung carcinoma
23. Lobectomy - Video-assisted thoracic surgery, versus muscle-sparing thoracotomy. A randomized trial
24. Multimodality therapy of patients with stage IIIA N2 non-small cell lung cancer
25. Positron emission tomography in lung cancer
26. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung
27. Survival after resection of stage II non-small cell lung cancer
28. Mediastinal lymph node dissection for lung cancer. The Memorial experience
29. Preoperative chemotherapy for stage IIIA (N2) lung cancer: The Memorial Sloan Kettering experience with 136 patients
30. Factors influencing ten-year survival in resected stages I to IIIA non-small cell lung cancer
31. Frequency of residual and metastatic tumors in patients undergoing curative surgical resections for lung cancer
32. Cancer therapy based on p53
33. Is lobectomy by video-assisted thoracic surgery an adequate cancer operation?
34. Mediastinoscopy, thoracoscopy, and video-assisted thoracic surgery in the diagnosis and staging of lung cancer
35. Revisions in the international system for staging lung cancer
36. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group
37. Prognosis and survival in resected lung carcinoma based on the new international staging system
38. Implications of staging in lung cancer
39. Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: A randomized study
40. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer
41. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis
42. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer
43. Significance of metastatic disease in subaortic lymph nodes
44. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung
45. Induction paclitaxel and carboplatin in early stage non-small cell lung cancer: Early results of a completed phase II trial
46. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomized controlled trials. PORT Meta-analysis Trialists Group
47. Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors
48. Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer
49. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
50. The survival of patients with inoperable lung cancer: A large-scale randomized study of radiation therapy versus placebo
51. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer
52. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
53. Gene therapy for non-small cell lung cancer: A preliminary report of a phase I trial of adenoviral p53 gene replacement
54. Surgical resection of stage IIIA and IIIB non-small cell lung cancer after concurrent induction chemo-radiotherapy
55. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer
56. Evolving techniques and technology in cardiac surgery
57. Robotic computer-assisted telemanipulation enhances coronary artery bypass
58. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long term follow up in 41 patients
59. The current status of adjuvant chemotherapy for resected non-small cell lung cancer
60. The role of post-operative radiotherapy in non-small-cell lung cancer: A multicentre randomized trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party
61. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
62. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell lung cancer: Report of a CALGB phase II study
63. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study)
64. Simultaneous cis-platinum, fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III NSCLC
65. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer
66. Prospective detection of preclinical lung cancer: Results from two studies of hnRNP A2/B1 overexpression
67. Postoperative radiation therapy in lung cancer: A controlled trial after resection of curative design
68. Lymph node staging in non-small cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients
69. FDG-PET scan in potentially operable non-small cell lung cancer: Do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?
70. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas
71. Adjuvant chemotherapy after complete resection in non-small cell lung cancer
72. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation
73. Preoperative chemotherapy (cis-platinum and fluorouracil) and radiation therapy in non-small cell lung cancer: A study of the Lung Cancer Study Group
74. 3-D conformal radiotherapy in the sagittal plane for centrally located thoracic tumors
75. Production of interleukin-10 by alveolar macrophages from lung cancer patients
76. Preoperative chemotherapy and radiation therapy for stage IIIA carcinoma of the lung